Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 2873 entries
View as:

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

Phase: N/A Priority: Normal
NCT ID: NCT06434350 Org: User:
Start: 10/10/24 End: 09/24/27 Due: 09/24/28

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04447222 Org: User:
Start: 05/12/20 End: 07/30/26 Due: 07/30/27

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Phase: N/A Priority: Normal
NCT ID: NCT00502203 Org: User:
Start: 08/31/01 End: 11/30/10 Due: 11/30/11

Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00527891 Org: User:
Start: 06/30/04 End: - Due: -

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

Phase: N/A Priority: Normal
NCT ID: NCT02274506 Org: User:
Start: 10/20/14 End: 10/20/14 Due: 10/20/15

REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)

Phase: N/A Priority: Normal
NCT ID: NCT05632809 Org: User:
Start: 01/10/23 End: 12/31/27 Due: 12/31/28

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

Phase: N/A Priority: Normal
NCT ID: NCT06181656 Org: User:
Start: 02/05/24 End: 09/30/25 Due: 09/30/26

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03579927 Org: User:
Start: 10/03/19 End: 10/03/19 Due: 10/03/20

A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06213311 Org: User:
Start: 05/07/24 End: 01/31/27 Due: 01/31/28

Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02677012 Org: User:
Start: 02/04/16 End: 07/03/20 Due: 07/03/21

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01410942 Org: User:
Start: 02/08/12 End: 09/30/26 Due: 09/30/27

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02812056 Org: User:
Start: 09/30/16 End: - Due: -

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00354523 Org: User:
Start: 12/31/04 End: 08/31/13 Due: 08/31/14

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

Phase: N/A Priority: Normal
NCT ID: NCT00791271 Org: User:
Start: 09/02/08 End: 05/31/15 Due: 05/31/16

Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study

Phase: N/A Priority: Normal
NCT ID: NCT01706705 Org: User:
Start: 10/22/12 End: 04/22/18 Due: 04/22/19

C-VISA BikDD: Liposome in Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00968604 Org: User:
Start: 03/31/15 End: 03/31/17 Due: 03/31/18

Taxotere/Temodar/Cisplatin Study in Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00527761 Org: User:
Start: 08/31/04 End: 11/30/07 Due: 11/30/08

Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02807883 Org: User:
Start: 08/31/16 End: 02/01/22 Due: 02/01/23

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

Phase: N/A Priority: Normal
NCT ID: NCT02740127 Org: User:
Start: 06/30/16 End: 05/10/20 Due: 05/10/21

Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00317772 Org: User:
Start: 09/02/04 End: 11/04/20 Due: 11/04/21

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Phase: N/A Priority: Normal
NCT ID: NCT00750737 Org: User:
Start: 06/30/08 End: 06/30/12 Due: 06/30/13

FTS Study in Patients With Advanced Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00867230 Org: User:
Start: 05/31/06 End: 02/28/09 Due: 02/28/10

IACS-010759 in Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03291938 Org: User:
Start: 11/13/17 End: 11/23/20 Due: 11/23/21

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT03449108 Org: User:
Start: 04/27/18 End: 04/30/27 Due: 04/30/28

Use of Water Warming/Cooling Garment to Maintain a Constant Intraoperative Core Target Temperature in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Proof-of-Concept Study

Phase: N/A Priority: Normal
NCT ID: NCT05474352 Org: User:
Start: 06/14/22 End: 05/03/23 Due: 05/03/24